CircRNAs in Alzheimer's disease: What are the prospects?
Authors:
Open Access
- 1 March 2024
- journal article
- review article
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 9 (1) , 203-210
Abstract
Circular RNAs (circRNAs) is a fascinating covalently closed circular non-coding RNA that is abundantly present in the transcriptome of eukaryotic cells. Its versatile nature allows it to participate in a multitude of pathological and physiological processes within the organism. One of its crucial functions is acting as a microRNA sponge, modulating protein transcription levels, and forming interactions with essential RNA-binding proteins. Remarkably, circRNAs demonstrates a specific enrichment in various vital areas of the brain, including the cortex, hippocampus, white matter, and photoreceptor neurons, particularly in aging organisms. This intriguing characteristic has led scientists to explore its potential as a significant biological marker of neurodegeneration, offering promising insights into neurodegenerative diseases like Alzheimer's disease (AD). In AD, there has been an interesting observation of elevated levels of circRNAs in both peripheral blood and synaptic terminals of affected individuals. This intriguing finding raises the possibility that circRNAs may have a central role in the initiation and progression of AD. Notably, different categories of circRNAs, including HDAC9, HOMER1, Cwc27, Tulp4, and PTK2, have been implicated in driving the pathological changes associated with AD through diverse mechanisms. For instance, these circRNAs have been demonstrated to contribute to the accumulation of beta-amyloid, which is a hallmark characteristic of AD. Additionally, these circRNAs contribute to the excessive phosphorylation of tau protein, a phenomenon associated with neurofibrillary tangles, further exacerbating the disease. Moreover, they are involved in aggravating neuroinflammation, which is known to play a critical role in AD's pathogenesis. Lastly, these circRNAs can cause mitochondrial dysfunction, disrupting cellular energy production and leading to cognitive impairment. As researchers delve deeper into the intricate workings of circRNAs, they hope to unlock its full potential as a diagnostic tool and therapeutic target for neurodegenerative disorders, paving the way for innovative treatments and better management of such devastating conditions.Keywords
This publication has 84 references indexed in Scilit:
- PURA , the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functionsGene, 2018
- Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cellsJournal of Cellular Biochemistry, 2017
- Alzheimer's diseaseEuropean Journal of Neurology, 2017
- The circular RNA ciRS‐7 promotes APP and BACE1 degradation in an NF‐κB‐dependent mannerThe FEBS Journal, 2017
- Memory deficits, gait ataxia and neuronal loss in the hippocampus and cerebellum in mice that are heterozygous for Pur-alphaNeuroscience, 2016
- Circular RNAs: analysis, expression and potential functionsDevelopment, 2016
- Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically ExpressedMolecular Cell, 2015
- Neural circular RNAs are derived from synaptic genes and regulated by development and plasticityNature Neuroscience, 2015
- Evidence HDAC9 Genetic Variant Associated With Ischemic Stroke Increases Risk via Promoting Carotid AtherosclerosisStroke, 2013
- The tubby family proteinsGenome Biology, 2011